BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2752939)

  • 1. [A model of the interclonal interactions in chronic myeloleukemia].
    Mamaev NN; Gushchin VA
    Eksp Onkol; 1989; 11(3):22-5. PubMed ID: 2752939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal relationship between a Ph-negative clone with trisomy 8 associated with severe myelodysplasia and a Ph-positive clone following imatinib treatment in a patient with accelerated-phase chronic myelogenous leukemia (CML).
    Patchenko P; Klepfish A; Trakhtenbrot L; Rothman R; Rachmilewitz EA
    Am J Hematol; 2004 Dec; 77(4):420. PubMed ID: 15558793
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
    Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Philadelphia negative, Bcr-Abl positive chronic myeloid leukemia associated with pure red cell aplasia.
    Karti S; Yilmaz M; Sonmez M; Akdogan R; Ersoz S; Ucar F; Ovali E
    J Exp Clin Cancer Res; 2003 Jun; 22(2):341-2. PubMed ID: 12866588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and chemical selection of Ph-negative clones.
    Carlo-Stella C; Mangoni L; Piovani G; Garau D; Almici C; Rizzoli V
    Stem Cells; 1993 Oct; 11 Suppl 3():77-82. PubMed ID: 8298479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.
    Olavarria E; Parker S; Craddock C; Philpott N; Tiniakou M; Chase A; Kanfer E; Apperley JF; Goldman JM
    Haematologica; 2000 Jun; 85(6):647-52. PubMed ID: 10870123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous splenic rupture in atypical (Philadelphia chromosome negative) chronic myeloid leukaemia following blastic crisis.
    Sachithanandan A; Gleadhill I; Alexander HD; Morris TC
    Ir Med J; 2003 Jun; 96(6):181-2. PubMed ID: 12926761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome.
    Jin Huh H; Won Huh J; Myong Seong C; Lee M; Soon Chung W
    Am J Hematol; 2003 Nov; 74(3):218-20. PubMed ID: 14587058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
    Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modeling of genesis and treatment of chronic myeloid leukemia.
    Horn M; Loeffler M; Roeder I
    Cells Tissues Organs; 2008; 188(1-2):236-47. PubMed ID: 18303243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atypical chronic myeloid leukemia presenting with trilineage dysplasia and IgG (lambda) type monoclonal gammopathy].
    Itoh K; Kashimura T; Kobayashi Y; Yagasaki F; Sakata T; Kawai N; Matsuda A; Kusumoto S; Fukuda M; Ino H; Murohashi I; Jinnai I; Yoshida S; Bessho M; Saitoh M; Hirashima K
    Rinsho Ketsueki; 1999 Feb; 40(2):129-34. PubMed ID: 10199207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observations.
    O'Brien S; Kantarjian HM; Talpaz M; Cork A; Trujillo J; Beran M
    Hematol Pathol; 1987; 1(3):167-72. PubMed ID: 3509052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse in chronic myeloid leukemia after bone marrow transplantation: biomathematical modeling as a new approach to understanding pathogenesis.
    Vincent PC; Rutzen-Loesevitz L; Tibken B; Heinze B; Hofer EP; Fliedner TM
    Stem Cells; 1999; 17(1):9-17. PubMed ID: 10215403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemia.
    Barnes DJ; Schultheis B; Adedeji S; Melo JV
    Oncogene; 2005 Sep; 24(42):6432-40. PubMed ID: 16007188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
    Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
    Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
    Farhi DC; Luckey CN; Siddiqui AM
    Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
    Phan TX; Hoang AV; Huynh VM; Nguyen KT; Nguyen TB; Huynh N; Pham QT; Tran VB; Tran VB; Tokunaga K; Sato Y
    Cancer Genet Cytogenet; 2006 Jul; 168(1):59-68. PubMed ID: 16772122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.